We are live on ! Find out more
ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

66 hedge funds and large institutions have $77M invested in Zynerba Pharmaceuticals, Inc in 2017 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 20

27% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 15

10% more funds holding

Funds holding: 60 → 66 (+6)

9% more capital invested

Capital invested by funds: $70.5M → $77M (+$6.53M)

41% less call options, than puts

Call options by funds: $17.1M | Put options by funds: $28.8M

Holders
66
Holders Change
+6
Holders Change %
+10%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
19
Reduced
15
Closed
20
Calls
$17.1M
Puts
$28.8M
Net Calls
-$11.7M
Net Calls Change
-$14.1M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.17M
2
JP Morgan Chase
JP Morgan Chase
New York
+$6.48M
3
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$6.03M
4
Deutsche Bank
Deutsche Bank
Germany
+$4.44M
5
Citigroup
Citigroup
New York
+$4.38M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$10.1M
2
PA
Perceptive Advisors
New York
-$5M
3
SFM
Sphera Funds Management
Israel
-$2.01M
4
MWA
Marshall Wace Asia
Hong Kong
-$1.65M
5
MWNA
Marshall Wace North America
New York
-$1.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$343K +$402K +20,200 New
TA
27
Teachers Advisors
New York
$341K +$400K +20,123 New
Charles Schwab
28
Charles Schwab
California
$326K +$382K +19,200 New
Millennium Management
29
Millennium Management
New York
$285K -$289K -14,526 -46%
UBS Group
30
UBS Group
Switzerland
$244K +$208K +10,457 +268%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$232K +$272K +13,683 New
PPA
32
Parametric Portfolio Associates
Washington
$223K +$261K +13,121 New
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$207K +$243K +12,200 New
Simplex Trading
34
Simplex Trading
Illinois
$189K -$240K -12,064 -52%
GCP
35
GSA Capital Partners
United Kingdom
$185K -$396K -19,900 -65%
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$158K +$186K +9,356 New
FMA
37
FNY Managed Accounts
New York
$127K -$29.8K -1,500 -17%
AIG
38
American International Group
New York
$120K +$141K +7,073 New
NFA
39
Nationwide Fund Advisors
Ohio
$110K +$129K +6,499 New
CG
40
Cutler Group
California
$100K +$118K +5,938 New
Group One Trading
41
Group One Trading
Illinois
$78K +$91.4K +4,596 New
FO
42
FT Options
Illinois
$42K +$49.7K +2,500 New
Legal & General Group
43
Legal & General Group
United Kingdom
$30K +$33.4K +1,680 New
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$20.3K +$23.7K +1,194 +119,400%
LTFS
45
Ladenburg Thalmann Financial Services
Florida
$19K -$2.21K -111 -9%
IA
46
IFP Advisors
Florida
$19K +$11.2K +565 +105%
AIP
47
Ameritas Investment Partners
Nebraska
$17K +$19.9K +1,001 New
Wells Fargo
48
Wells Fargo
California
$15K +$3.98K +200 +29%
Creative Planning
49
Creative Planning
Kansas
$15K +$13.9K +700 +409%
AG
50
Advisor Group
Arizona
$14K -$8.35K -420 -34%
1
2
3 4

ZYNE Hedge Fund Activity: Q2 2017 in Review

66 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Zynerba Pharmaceuticals, Inc (ZYNE) for Q2 2017, worth a combined $77M — up 9.3% from $70.5M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ZYNE positions and 20 closed out — a net gain of 6 holders — while 19 added to existing stakes and 15 trimmed.

The largest buyer was BlackRock, adding an estimated $9.17M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $10.1M sold.

  • 66 institutional investors held Zynerba Pharmaceuticals, Inc (ZYNE) as of Q2 2017, up from 60 in Q1 2017.
  • Funds reported $77M of Zynerba Pharmaceuticals, Inc stock for Q2 2017, up 9.3% quarter-over-quarter.
  • 26 funds opened new Zynerba Pharmaceuticals, Inc positions in Q2 2017 and 20 closed out, a net change of +6 holders.
  • The largest Zynerba Pharmaceuticals, Inc buyer in Q2 2017 was BlackRock, an estimated $9.17M added.
  • The largest Zynerba Pharmaceuticals, Inc seller in Q2 2017 was Cormorant Asset Management, an estimated $10.1M sold.

Based on aggregated 13F filings for Q2 2017.